A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
A phase 2 trial of Golcadomide, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone in non-Hodgkin lymphoma, run by Celgene, active and no longer recruiting.
Overview
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma is a phase 2 interventional study registered as NCT06425302 by Celgene, with 95 participants enrolled, started 2024-08-30 and due to reach its primary completion in 2026-06-19. Interventions recorded: Golcadomide, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone.
Similar pages
not linked directly; found by shared links- TrialTucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Shares Prednisone, Vincristine, Cyclophosphamide, Doxorubicin and the tag pipeline.
- TrialA Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
Shares Prednisone, Vincristine, Rituximab, Doxorubicin and the tag pipeline.
- TrialSafety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide and the tag pipeline.
- TrialA Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)
Shares Prednisone, Cyclophosphamide, Doxorubicin, Non-Hodgkin lymphoma (all types) and the tag pipeline.
- TrialA Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)
Shares Prednisone, Rituximab, Cyclophosphamide, Doxorubicin and the tag pipeline.
- TrialA Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Shares Prednisone, Rituximab, Cyclophosphamide, Doxorubicin and the tag pipeline.
- TrialA Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Shares Rituximab, Non-Hodgkin lymphoma (all types), Bristol Myers Squibb and the tag pipeline.
- TrialEfficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed/Refractory Marginal Zone Lymphoma
Shares Rituximab, Non-Hodgkin lymphoma (all types) and the tag pipeline.